Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C R Settanni"'
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
Autor:
C. Caruso, L. Laterza, C. R. Settanni, S. Colantuono, C. Di Mario, B. Tolusso, F. Castrì, E. Gremese, F. Scaldaferri, A. Armuzzi, C. De Simone, K. Peris, A. Chiricozzi, A. Gasbarrini
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
We described a case of IPEX syndrome successfully controlled with dupilumab, an anti-IL4 receptor alpha subunit inhibitor. IPEX syndrome is a rare and generally fatal genetic disorder characterized by immune dysregulation, polyendocrinopathy and ente
Externí odkaz:
https://doaj.org/article/96e741e104df4a0583ef8abba24751dc
Autor:
D Napolitano, C R Settanni, L Parisio, E Schiavoni, D Pugliese, F Scaldaferri, A Gasbarrini, A Papa
Publikováno v:
Journal of Crohn's and Colitis. 17:i1039-i1040
Background Therapeutic armamentarium of inflammatory bowel disease (IBD) has expanded, including several intravenous (IV) and subcutaneously administered biological agents and orally administered small molecules (SMs). Additionally, some biologics in
Autor:
I Mignini, L Masucci, F De Maio, L Laterza, F Scaldaferri, C R Settanni, D Napolitano, S Baroni, M Garcovich, L Riccardi, A Gasbarrini, P M Ferraro, A Papa
Publikováno v:
Journal of Crohn's and Colitis. 17:i405-i406
Background Nephrolithiasis (NL) is a common extra-intestinal complication of inflammatory bowel disease (IBD) with recognizable morbidity and mortality. However, its pathogenesis and risk factors are not completely elucidated yet. Because of intestin
Autor:
P Puca, I Capobianco, V Petito, L Masi, M Fidaleo, F Del Chierico, I Palucci, L R Lopetuso, L Laterza, C R Settanni, L Parisio, S Bibbò, D Pugliese, A Armuzzi, G Pani, A Gasbarrini, F Scaldaferri
Publikováno v:
Journal of Crohn's and Colitis. 16:i396-i396
Background Ulcerative colitis is a chronic invalidating disease, whose therapeutic strategies include amino-salicylates, steroids, probiotics, immune-modulators, biologics, fecal microbiota transplantation and surgery. In clinical practice, there is
Autor:
Giulia Savera, Maria Assunta Zocco, F. Crudo, Simona Marchetti, Maurizio Sanguinetti, G. Giuseppin, Davide Moschese, Francesco Franceschi, Francesco Landi, Giulia Bramato, M. M. Lizzio, E. Tamburrini, C. Culiersi, Angelo Carfì, M. Santantonio, A. Lauria, Riccardo Calvani, G. C. Passali, A. Calabrese, Giovanni Addolorato, Delfina Janiri, S. Di Gianbenedetto, L. Catalano, Luca Petricca, Luca Santoro, Danilo Buonsenso, Paola Cattani, V. Popolla, Antonio Nesci, Elisabetta Rota, M. Modica, C. De Rose, Emanuele Marzetti, P. Valentini, Arturo Ciccullo, Anna Maria Martone, R. Murri, A. Santoliquido, A. Bizzarro, Francesca Ciciarello, Davide Pata, Antonio Gasbarrini, J. Galli, A. Cingolani, M. R. Lo Monaco, G. M. Cozzupoli, C. R. Settanni, Marcello Tritto, G. Natalello, Y. Longobardi, Roberto Bernabei, Matteo Tosato, Sara Rocchi, Andrea Salerno, R. Marano, G. Di Cintio, A. R. Larici, Dario Sinatti, A. Borghetti, L. Gigante, G. Gambini, L. Stella, Anna Picca, Stanislao Rizzo, C. Napolitano, Gabriele Sani, G. Mingrone, L. Richeldi, L. Natale, Massimo Fantoni, A. L. Fedele, E. Taddei, M. Molinaro, L. Tricarico, Elisa Gremese, M. C. Savastano, G. Paludetti, G. Ventura, Francesca Benvenuto, Francesco Pagano, F. Lombardi, Annamaria Paglionico
Publikováno v:
Aging Clinical and Experimental Research
For survivors of severe COVID-19 disease, having defeated the virus is just the beginning of an uncharted recovery path. What follows after the acute phase of SARS-CoV-2 infection depends on the extension and severity of viral attacks in different ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3212ae6a990bcc72a7e5a1f7893c82
http://hdl.handle.net/10807/164713
http://hdl.handle.net/10807/164713